Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan B Fleischer

Showing results (41-50 of 282) with videos related to

Pageof 29
Sort By:
Cutis|June 8, 2011
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implicationsSteven R Feldman, Alan B Fleischer
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 4, 2022
Workforce Requirements for Skin Cancer and Related Skin Tumors Continue to Increase: Clinicians Expend an Average of 1,740 Full-Time Effort Years AnnuallyGabrielle M Peck, Alan B Fleischer
Journal of Drugs in Dermatology : JDD|November 11, 2010
Changes in rosacea comorbidities and treatment utilization over timeBrad A Yentzer, Alan B Fleischer
Journal of the National Medical Association|March 6, 2017
Higher Risk of Care for Hidradenitis Suppurativa in African American and Non-Hispanic Patients in the United StatesNneka S Udechukwu, Alan B Fleischer
Expert Opinion on Pharmacotherapy|October 6, 2004
Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous diseaseChristie L Carroll, Alan B Fleischer
Photodermatology, Photoimmunology & Photomedicine|October 18, 2024
Warmer Temperatures Are More Predictive Than Solar Radiation for the Number of Skin Cancer Removal ProceduresBrad R Woodie, Alan B Fleischer
Photodermatology, Photoimmunology & Photomedicine|March 29, 2025
Ambient Solar Radiation Predicts Psoriasis Treatment IntensityBrad R Woodie, Alan B Fleischer
Journal of Drugs in Dermatology : JDD|July 8, 2015
An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea PedisAmit Verma, Babajide Olayinka, Alan B Fleischer
The Journal of Dermatological Treatment|October 26, 2020
The cost of liver function tests for terbinafine: an unnecessary expenseSuraj Muddasani, Anne Housholder, Alan B Fleischer
The Journal of Dermatological Treatment|October 20, 2020
Systemic ketoconazole continues to be prescribed despite an FDA warningSuraj Muddasani, Gabrielle Peck, Alan B Fleischer
Pageof 29

Showing results (41-50 of 282) with videos related to

Sort By:
Pageof 29
Cutis|June 8, 2011
Progression of actinic keratosis to squamous cell carcinoma revisited: clinical and treatment implicationsSteven R Feldman, Alan B Fleischer
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|March 4, 2022
Workforce Requirements for Skin Cancer and Related Skin Tumors Continue to Increase: Clinicians Expend an Average of 1,740 Full-Time Effort Years AnnuallyGabrielle M Peck, Alan B Fleischer
Journal of Drugs in Dermatology : JDD|November 11, 2010
Changes in rosacea comorbidities and treatment utilization over timeBrad A Yentzer, Alan B Fleischer
Journal of the National Medical Association|March 6, 2017
Higher Risk of Care for Hidradenitis Suppurativa in African American and Non-Hispanic Patients in the United StatesNneka S Udechukwu, Alan B Fleischer
Expert Opinion on Pharmacotherapy|October 6, 2004
Tacrolimus ointment: the treatment of atopic dermatitis and other inflammatory cutaneous diseaseChristie L Carroll, Alan B Fleischer
Photodermatology, Photoimmunology & Photomedicine|October 18, 2024
Warmer Temperatures Are More Predictive Than Solar Radiation for the Number of Skin Cancer Removal ProceduresBrad R Woodie, Alan B Fleischer
Photodermatology, Photoimmunology & Photomedicine|March 29, 2025
Ambient Solar Radiation Predicts Psoriasis Treatment IntensityBrad R Woodie, Alan B Fleischer
Journal of Drugs in Dermatology : JDD|July 8, 2015
An Open-Label, Multi-Center, Multiple-Application Pharmacokinetic Study of Naftifine HCl Gel 2% in Pediatric Subjects With Tinea PedisAmit Verma, Babajide Olayinka, Alan B Fleischer
The Journal of Dermatological Treatment|October 26, 2020
The cost of liver function tests for terbinafine: an unnecessary expenseSuraj Muddasani, Anne Housholder, Alan B Fleischer
The Journal of Dermatological Treatment|October 20, 2020
Systemic ketoconazole continues to be prescribed despite an FDA warningSuraj Muddasani, Gabrielle Peck, Alan B Fleischer
Pageof 29